Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2024-03-19 00:00:00 ET · period of report 2024-03-15 · accession 0001819790-24-000044 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-19 | 2024-03-18 | TARS | Whitfield Dianne C. | CHRO | S - Sale+OE | $30.60 | -4,314 | 34.2K | -11% | -$132.0K |
| D | 2024-03-19 | 2024-03-15 | TARS | Whitfield Dianne C. | CHRO | M - OptEx | — | +11.7K | 38.5K | +44% | — |
| DM | 2024-03-19 | 2024-03-15 | TARS | Whitfield Dianne C. | CHRO | M - OptEx | $0.00 | -11.7K | 21.7K | -35% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-18 | S | D | 4,314 | $30.60 | 34,181 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-15 | M | A | 11,711 | — | 38,495 | D | — | — | (F1) The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). |
| 3 | Derivative | Restricted Stock Units | 2024-03-15 | M | D | 4,463 | $0.00 | 8,925 | D | — · — to — | 4,463 Common Stock | (F3) Each RSU represents a contingent right to receive one share of the Issuer's common stock. (F4) RSUs granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. The RSUs will vest in equal installments on March 15, 2023, March 15, 2024, March 15, 2025 and March 15, 2026, subject to the Reporting Person's continuous service. |
| 4 | Derivative | Restricted Stock Units | 2024-03-15 | M | D | 7,248 | $0.00 | 21,745 | D | — · — to — | 7,248 Common Stock | (F3) Each RSU represents a contingent right to receive one share of the Issuer's common stock. (F5) RSUs granted on March 8, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. The RSUs will vest in equal installments on March 15, 2024, March 15, 2025, March 15, 2026 and March 15, 2027, subject to the Reporting Person's continuous service. |